Poor oral health (Fig. 3) and extensive stomatitis, responsible for significant morbidity, are common in patients receiving cancer therapies[15–18]. Oral mucosal lesions may provide a portal of entry for systemic infection that may prevent or delay the continuation of cancer treatment [19–21]